Search for: "FOREST LABS V US" Results 21 - 40 of 97
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 May 2007, 12:07 pm
The primary examples of enantiomer patents that we regard as vulnerable include Forest Labs' Lexapro, Bristol-Myers' Plavix, AstraZeneca's Nexium and Johnson & Johnson's Levaquin. [read post]
3 Jun 2022, 6:53 pm by Lawrence B. Ebert
Cir. 2022), and any sub sidiary fact findings about extrinsic evidence for clear er ror, Forest Labs., LLC v. [read post]
11 Sep 2007, 9:55 pm
Another interesting aspect of today's decision is that just six days ago, in Forest Labs v. [read post]
27 Feb 2009, 5:00 am
(Patent Docs) Lexapro (Escitalopram) – US: Supreme Court refuses to hear appeal from Forest Lab’s allowing Caraco to continue bid to invalidate Lexapro patent despite Forest’s earlier covenant to sue (Law360) (Hal Wegner) Lotrel (Amlodipine) – US: Par and Novartis settle Lotrel lawsuit (Patent Docs) (GenericsWeb) Lovenox (Enoxaparin) – US: Amphastar antitrust claims nixed in Lovenox suit… [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to… [read post]
11 Oct 2010, 9:45 pm by Aaron Barkoff
  The patent owner, Forest Labs, sued Ivax on the EEP but not the LEP. [read post]
27 Jun 2008, 10:45 am
As the District Court for the District of Columbia put it while granting summary judgment to the government in American Forest Research Council v. [read post]
28 Oct 2009, 6:15 am
(The SPC Blog) EU: European Federation of Pharmaceutical Industries and Associations unveils anti-counterfeit authentication system (IP Watch) US: Time Magazine on data exclusivity debate (Patent Docs) US: BIO's IPCC Conference: Behind the scenes look at patent cases - Mayo v Prometheus; Bilski v Doll; Laboratory Court of Am. [read post]
28 Oct 2009, 6:15 am
(The SPC Blog) EU: European Federation of Pharmaceutical Industries and Associations unveils anti-counterfeit authentication system (IP Watch) US: Time Magazine on data exclusivity debate (Patent Docs) US: BIO's IPCC Conference: Behind the scenes look at patent cases - Mayo v Prometheus; Bilski v Doll; Laboratory Court of Am. [read post]
28 Oct 2009, 7:15 am
(The SPC Blog) EU: European Federation of Pharmaceutical Industries and Associations unveils anti-counterfeit authentication system (IP Watch) US: Time Magazine on data exclusivity debate (Patent Docs) US: BIO’s IPCC Conference: Behind the scenes look at patent cases – Mayo v Prometheus; Bilski v Doll; Laboratory Court of Am. [read post]